Efficacy and safety of 177Lu-DOTATATE targeted therapy in advanced/metastatic pulmonary neuroendocrine tumors: A systematic review and meta-analysis

MLA

Jiao Ma, et al. “Efficacy and Safety of 177Lu-DOTATATE Targeted Therapy in Advanced/Metastatic Pulmonary Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.” Frontiers in Oncology, vol. 12, Nov. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.993182.

APA

Jiao Ma, Xin Hu, Lanying Li, Zijuan Rao, & Chunyin Zhang. (2022). Efficacy and safety of 177Lu-DOTATATE targeted therapy in advanced/metastatic pulmonary neuroendocrine tumors: A systematic review and meta-analysis. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.993182

Chicago

Jiao Ma, Xin Hu, Lanying Li, Zijuan Rao, and Chunyin Zhang. 2022. “Efficacy and Safety of 177Lu-DOTATATE Targeted Therapy in Advanced/Metastatic Pulmonary Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.” Frontiers in Oncology 12 (November). doi:10.3389/fonc.2022.993182.